Healthcare Sales & Marketing Network News: MD Anderson

Searching News Database: MD Anderson

HSMN NewsFeed - 22 Aug 2025
Sonic Healthcare USA, Inc. Announces Acquisition of Cairo Diagnostics LLC to Expand Sonic's National Hematology Oncology Testing Capabilities
Diagnostics Oncology Mergers & Acquisitions

HSMN NewsFeed - 2 Jan 2025
Movano Health Welcomes Dr. Shaheen Wirk to its Board of Directors
Devices Monitoring Personnel

HSMN NewsFeed - 30 Apr 2024
Innovent Announces the Appointment of Dr. Samuel Zhang as Global Chief Business Officer (CBO)
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Apr 2024
Orna Therapeutics Appoints Frank Neumann, M.D., Ph.D., as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Sep 2023
OncoResponse Announces Appointment of Carol Gallagher to Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 20 Sep 2022
MD Anderson Cancer Center Selects ViewRay to Expand MR-Guided Radiation Therapy Program
Devices Oncology

HSMN NewsFeed - 23 Jun 2022
CNS Pharmaceuticals Receives Approval from U.S. FDA for Protocol Amendment to Ongoing Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 20 Jan 2022
Alpha Tau Announces New Research Collaboration to Study the Potential of Alpha DaRT to Enhance Immune Stimulation in the Treatment of Breast Cancer
Devices Oncology

HSMN NewsFeed - 22 Sep 2021
Kintara Reports Topline Results from Phase 2 Clinical Study of VAL-083 as Adjuvant Therapy for Newly-Diagnosed GBM Patients
Biopharmaceuticals Oncology

HSMN NewsFeed - 11 Aug 2021
Ethicon's Echelon Circular Powered Stapler Associated With Major Reduction In Serious Complications Following Colorectal Surgery
Devices Surgery

HSMN NewsFeed - 12 Jul 2021
Hummingbird Bioscience and MD Anderson Announce Strategic Research Collaboration To Advance Innovative Immunotherapies
Biopharmaceuticals Oncology

HSMN NewsFeed - 29 Jun 2021
FDA Grants Fast Track Designation to CNS Pharmaceuticals for Berubicin for the Treatment of Recurrent Glioblastoma Multiforme
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 10 May 2021
Allergan Aesthetics to Acquire Soliton, Expanding Body Contouring Portfolio
Devices Dermatology Mergers & Acquisitions

HSMN NewsFeed - 29 Apr 2021
Soliton Receives FDA Clearance of Special 510(k)
Devices Dermatology FDA

HSMN NewsFeed - 29 Mar 2021
Phoenix Molecular Designs Appoints Biotech Powerhouse, Michael Varney, Ph.D., to its Advisory Board
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 22 Mar 2021
Sirtex Medical announces new SIR-Spheres(R) DOORwaY-90 Study: The first prospective multicenter U.S.-based trial for registration as first-line treatment for hepatocellular carcinoma
Devices Oncology

HSMN NewsFeed - 16 Mar 2021
Merck KGaA, Darmstadt, Germany, Reports Topline Data for Bintrafusp Alfa as Second-Line Monotherapy Treatment in Biliary Tract Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 1 Feb 2021
Soliton Announces FDA Clearance of Rapid Acoustic Pulse Technology for Use in Cellulite
Devices Dermatology FDA

HSMN NewsFeed - 23 Dec 2020
Rakuten Medical Enrolls First Patient in the U.S. Clinical Trial for its Lead Product, ASP-1929 in Combination with Anti-PD1 Therapy, for Head and Neck Cancer or Cutaneous Squamous Cell Carcinoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 23 Nov 2020
Innovent Announces NMPA Granted New Indication Approval for SULINNO(R) (Adalimumab Injection) in China for the Treatment of Polyarticular Juvenile Idiopathic Arthritis
Biopharmaceuticals Regulatory

HSMN NewsFeed - 2 Nov 2020
Soliton Appoints Aesthetic Executive Veteran Brad Hauser as President and Chief Executive Officer in Preparation for Commercial Launch
Devices Dermatology Personnel Product Launch

HSMN NewsFeed - 9 Oct 2020
Innovent and Lilly Jointly Announce the NMPA Granted Marketing Approval for HALPRYZA(R) (Rituximab Injection) in China
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 11 Sep 2020
Targazyme Appoints Jim Caggiano as CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Sep 2020
Innovent Announces NMPA Granted Marketing Approval for SULINNO(R) (Adalimumab Injection) in China
Biopharmaceuticals Regulatory

HSMN NewsFeed - 18 Aug 2020
Innovent and Lilly Announce Expansion of TYVYT(R) (Sintilimab Injection) Licensing Agreement
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 23 Jul 2020
Quadriga BioSciences Initiates Clinical Trial of Innovative, Targeted Treatment for Brain Cancers
Biopharmaceuticals Oncology

HSMN NewsFeed - 27 May 2020
Acquist Therapeutics Announces New Appointments to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Apr 2020
Soliton Granted New Key Patent for FDA Cleared RAP Technology
Devices

HSMN NewsFeed - 1 Apr 2020
Soliton Announces New Launch Plan of Next Generation Acoustic Shockwave Product Due to COVID-19
Devices Dermatology Product Launch

HSMN NewsFeed - 11 Mar 2020
Soliton Receives FDA Clearance of Special 510(k)
Devices Dermatology FDA

HSMN NewsFeed - 11 Feb 2020
Soliton Files Special 510(k) with FDA for its Generation II RAP Device
Devices Dermatology FDA

HSMN NewsFeed - 13 Jan 2020
CNS Pharmaceuticals Licenses DNA-Binding Agent from MD Anderson, Doubling its Drug Pipeline
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 10 Dec 2019
Soliton Appoints Mary Stoll as Senior Director of Clinical Development
Devices Dermatology Personnel

HSMN NewsFeed - 26 Nov 2019
CNS Pharmaceuticals Entered $2.0 Million Sublicense Agreement with WPD Pharmaceuticals
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 19 Nov 2019
CNS Pharmaceuticals Acquired Worldwide Rights for Brain Cancer Drug from Houston Pharmaceuticals
Biopharmaceuticals Licensing

HSMN NewsFeed - 8 Nov 2019
Citius Pharmaceuticals Issues Corporate Update
Biopharmaceuticals

HSMN NewsFeed - 29 Oct 2019
Soliton's Recent Positive Data Increases Potential Fibrotic Indications
Devices Dermatology

HSMN NewsFeed - 29 Oct 2019
Disc Medicine Completes $50 Million Series A Financing led by Novo Holdings A/S to Advance New Therapies Addressing Ineffective Red Blood Cell Production
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 14 Aug 2019
Soliton Treats First Patients in Pivotal Cellulite Trial
Devices Dermatology

HSMN NewsFeed - 21 May 2019
DelMar Pharmaceuticals Announces Expansion of Scientific Advisory Board
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 17 May 2019
Soliton Provides FDA Update and Addresses Recent Anonymous Article
Devices Dermatology FDA

HSMN NewsFeed - 4 Apr 2019
DelMar Pharmaceuticals Welcomes Dr. John de Groot, Chairman, ad interim of the Department of Neuro-Oncology at MD Anderson Cancer Center, as founding member of the Company's Scientific Advisory Board
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 21 Mar 2019
Soliton Files 510(k) with FDA for its Rapid Acoustic Pulse Device
Devices Dermatology FDA

HSMN NewsFeed - 4 Feb 2019
Elekta: New Study to Learn From Every Cancer Patient Treated With Magnetic Resonance Radiation Therapy
Devices Radiology Oncology

HSMN NewsFeed - 22 Aug 2018
Sierra Oncology Acquires Momelotinib, an Investigational Janus Kinase (JAK) 1/2 and Activin Receptor Type 1 (ACVR1) Inhibitor for Myelofibrosis, from Gilead Sciences
Biopharmaceuticals Oncology Acquisitions

HSMN NewsFeed - 20 Jul 2018
FDA Grants Approval of TIBSOVO(R), the First Oral, Targeted Therapy for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia and an IDH1 Mutation
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 9 Jul 2018
Polaris Announces Drs. James Allison and Padmanee Sharma Joining its Scientific Advisory Board
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 3 Apr 2018
Kleo Pharmaceuticals Inc. Appoints Luca Rastelli, PhD as Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Feb 2018
Senti Biosciences Secures $53 Million Series A to Build the Future of Gene and Cell-Based Therapies
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 25 Jan 2018
IRIS Announces Changes and Additions to Its Executive Leadership Team
Devices Ophthalmology Personnel

HSMN NewsFeed - 29 Nov 2017
Codiak BioSciences Closes $76.5 Million Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 25 Sep 2017
TapImmune Appoints Peter Hoang as President and Chief Executive Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 15 Sep 2017
NCCN Guidelines to Include Categories of Preference
Biopharmaceuticals Devices Oncology

HSMN NewsFeed - 3 Aug 2017
Elekta MR-linac Consortium Brings Founding Members Together With Clinicians From Five New Centers to Highlight Progress
Devices Oncology

HSMN NewsFeed - 19 Jul 2017
NCCN Guidelines and NCCN Templates to be Integrated into ION Solutions' IntelliDoseTxM Treatment Management Module
Devices Oncology

HSMN NewsFeed - 11 Jul 2017
DelMar Pharmaceuticals Appoints Saiid Zarrabian to the Board of Directors and Names Dr. Erich Mohr as Chairman
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 20 Jun 2017
NCCN Guidelines Compliance for Chest CT Reduces False Positives and Decreases Health Care Spending in Breast Cancer, Study Finds
Devices Oncology Radiology

HSMN NewsFeed - 30 Mar 2017
CytomX Therapeutics Appoints Marion McCourt to Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 20 Mar 2017
Bristol-Myers Squibb and CytomX Therapeutics Extend Worldwide Collaboration to Discover Probody(TM) Therapeutics for the Treatment of Cancer and Other Diseases
Biopharmaceuticals Oncology

HSMN NewsFeed - 9 Mar 2017
OncoResponse Announces Final Closing of $22.5M Series A Financing Round
Biopharmaceuticals Oncology Personnel Venture Capital

HSMN NewsFeed - 2 Mar 2017
BLINCYTO(R) (blinatumomab) Significantly Improved Overall Survival In Patients With B-Cell Precursor Acute Lymphoblastic Leukemia Compared To Chemotherapy
Biopharmaceuticals Oncology

HSMN NewsFeed - 9 Feb 2017
AAVP Biosystems Hires Mark Shapiro, M.D., Ph.D. as Chief Medical Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 9 Jan 2017
Amgen and Immatics Enter Strategic Collaboration to Develop Novel Bispecific Cancer Immunotherapies
Biopharmaceuticals Oncology

HSMN NewsFeed - 10 Oct 2016
OncoResponse Secures $7M in Supplemental Series A Funding
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 30 Sep 2016
Threshold Pharmaceuticals Announces Interim Results from Tarloxotinib Program and its Plans to Focus on Evofosfamide and Earlier-Stage Opportunities
Biopharmaceuticals Oncology

HSMN NewsFeed - 20 Sep 2016
Installation Initiated for Elekta’s High-Field MR-Adaptive Linear Accelerator at Froedtert & the Medical College of Wisconsin Clinical Cancer Center
Devices Oncology

HSMN NewsFeed - 19 May 2016
Elekta Surpasses One Million Patients Treated with Leksell Gamma Knife
Devices Oncology Neurosurgery

HSMN NewsFeed - 9 May 2016
U.S. FDA Expands IMBRUVICA(R) (ibrutinib) Label to Include Overall Survival Data in Previously Untreated Chronic Lymphocytic Leukemia (CLL) and New Indication for Small Lymphocytic Lymphoma (SLL) Patients
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 26 Apr 2016
MD Anderson Cancer Center to Acquire Elekta Linear Accelerators and Other Radiotherapy Solutions
Devices Oncology

HSMN NewsFeed - 21 Apr 2016
FDA Grants Orphan Drug Designation For VAL-083 In Ovarian Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 18 Apr 2016
Elekta and Philips Begin Installation of MR-Guided Linear Accelerator at The Netherlands Cancer Institute
Devices Oncology Radiology

HSMN NewsFeed - 28 Mar 2016
Lion Biotechnologies Names Michael T. Lotze Chief Scientific Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 18 Mar 2016
The Myriad myRisk(R) Hereditary Cancer Test Identifies 60 Percent More Deleterious Mutations in Patients with Endometrial Cancer
Diagnostics Oncology Personalized Medicine

HSMN NewsFeed - 4 Feb 2016
Lion Biotechnologies Names Steven A. Fischkoff Chief Medical Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 23 Jan 2016
Cellceutix Releases Data Used in Receiving FDA Orphan Drug Designation of Kevetrin for Pancreatic Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 18 Dec 2015
European Commission Approves Amgen's IMLYGIC(TM) (talimogene laherparepvec) As First Oncolytic Immunotherapy In Europe
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 17 Nov 2015
ARCH Venture Partners, Flagship Ventures and MD Anderson Collaborate to Launch Codiak BioSciences
Biopharmaceuticals Oncology Venture Capital Personnel

HSMN NewsFeed - 13 Oct 2015
Installation Completed for Elekta MRI-guided linear Accelerator at MD Anderson Cancer Center
Devices Oncology

HSMN NewsFeed - 12 Oct 2015
Seven US Medical Centers to Acquire Elekta's New Leksell Gamma Knife Icon Brain Radiosurgery System
Devices Neurosurgery Oncology

HSMN NewsFeed - 1 Oct 2015
Neon Therapeutics Launches with $55 Million Series A to Develop Neoantigen-based Cancer Immunotherapies
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 21 Sep 2015
ETView and The University of Texas MD Anderson Cancer Center (Houston, TX) Announce the Start of a Prospective, Randomized Clinical Evaluation of VivaSight-DL(TM) vs. Standard Double-Lumen Endotracheal Tubes
Devices

HSMN NewsFeed - 2 Jun 2015
ZIOPHARM Announces Caesar J. Belbel, Chief Legal Officer, Appointed Chief Operating Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 29 May 2015
Myriad Presents New myRisk(TM) Hereditary Cancer Data at 2015 ASCO Annual Meeting
Diagnostics Oncology

HSMN NewsFeed - 3 Apr 2015
MD Anderson, Astellas Pharma Sign Option Agreement for Monoclonal Antibody Drug Targeting Acute Myeloid Leukemia
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 31 Mar 2015
EDP Biotech Signs Distribution Partnership Agreements for ColoMarker(R) Abroad
Diagnostics Oncology Distribution

HSMN NewsFeed - 24 Feb 2015
ETView Reports on Clinical Evaluation of VivaSight(TM)
Devices

HSMN NewsFeed - 9 Feb 2015
Texas Center For Proton Therapy Names Dr. Andrew K. Lee Medical Director
Devices Oncology Personnel

HSMN NewsFeed - 27 Jan 2015
ONCOLIX, INC. Announces Capital Raise of $4.2 Million
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 5 Dec 2014
Bellicum Announces New Director, Executive Management Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 May 2014
Guardant Health Announces US Commercial Launch of Guardant360(TM): A Breakthrough Blood Test for Real-Time Cancer Patient Treatment Management
Diagnostics Oncology Product Launch

HSMN NewsFeed - 15 Apr 2014
Eventus Diagnostics Completes $2.72 Million Financing To Support Commercialization Of Its Octava(TM) Blood Tests For Breast Cancer Detection
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 26 Mar 2014
Bio-Path Holdings, Inc. Appoints Ulrich W. Mueller Chief Operating Officer
Biopharmaceuticals Drug Delivery Oncology Personnel

HSMN NewsFeed - 24 Jan 2014
Margaret A. Tempero, MD, Named Editor-in-Chief of JNCCN
Oncology Personnel

HSMN NewsFeed - 13 Jan 2014
Galena Biopharma Acquires Mills Pharmaceuticals, LLC
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 9 Jan 2014
Lion Biotechnologies Appoints James Bender, Ph.D., as Vice President, Product Development and Manufacturing
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 20 Dec 2013
Cellceutix Files Orphan Drug Designation Application for Brilacidin for Oral Mucositis with US FDA
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 18 Dec 2013
America Stem Cell, Inc. Changes Its Name to Targazyme, Inc.
Biopharmaceuticals Regenerative Medicine Oncology

HSMN NewsFeed - 15 Nov 2013
Germ-Zapping Robots Use Xenex’s Powerful, Pulsed UV Light to Improve Patient Safety at University Hospital
Devices

HSMN NewsFeed - 6 Nov 2013
Lion Biotechnologies Completes $23.3 Million Private Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 8 Oct 2013
MolecularHealth Continues to Grow Management Team with New Chief Commercial Officer
Diagnostics Personalized Medicine Oncology Personnel

HSMN NewsFeed - 20 Sep 2013
New York Proton Consortium Expands Access to Proton Therapy Through Agreement with ProCure Proton Therapy Center in New Jersey
Devices Oncology

HSMN NewsFeed - 16 Jul 2013
Froedtert & The Medical College of Wisconsin Clinical Cancer Center Joins Elekta and Philips Research Consortium on MRI-Guided Radiation Therapy
Devices Radiology Oncology

HSMN NewsFeed - 20 Apr 2013
Elekta and Philips Research Consortium on MRI-Guided Radiation Therapy Adds The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital
Devices Radiology Oncology

HSMN NewsFeed - 18 Apr 2013
MD Anderson Cancer Center Acquires Two Elekta Versa HD Systems
Devices Oncology

HSMN NewsFeed - 7 Feb 2013
Banner MD Anderson Cancer Center Acquires Multiple Elekta Cancer Management Systems
Devices Oncology

HSMN NewsFeed - 28 Jan 2013
New NCCN Guidelines for Patients(R) Available for Adolescents and Young Adults with Cancer
Biopharmaceuticals Devices Oncology

HSMN NewsFeed - 22 Jan 2013
NCCN Guidelines(R) Recommend NovoTTF(TM) Therapy as a Standard Treatment Option for CNS Cancers
Devices Oncology

HSMN NewsFeed - 14 Jan 2013
La Jolla Pharmaceutical Company Adds to Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Nov 2012
Mevion Medical Systems Continues Manufacturing Ramp up for its Revolutionary MEVION S250 Proton Therapy System
Devices Oncology

HSMN NewsFeed - 26 Oct 2012
Teva Receives Approval For SYNRIBO(TM) (Omacetaxine Mepesuccinate) for Injection
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 1 May 2012
Brachytherapy as Effective for Local Breast Cancer Control as Whole Breast Irradiation According to New Study
Devices Oncology

HSMN NewsFeed - 28 Mar 2012
Kapil Dhingra, Former Head of Roche Oncology, Joins Exosome Diagnostics Board of Directors
Diagnostics Personalized Medicine Oncology Personnel

HSMN NewsFeed - 20 Jan 2012
Galena Biopharma Initiates Patient Enrollment in NeuVax(TM) Phase 3 PRESENT Trial to Prevent Breast Cancer Recurrence
Biopharmaceuticals Oncology

HSMN NewsFeed - 27 Oct 2011
Arrowhead Research Appoints Bruce Given M.D. Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Aug 2011
New NCCN Patient Guidelines Help Patients Navigate the Maze of Breast Cancer Treatment Options
Oncology

HSMN NewsFeed - 13 Jun 2011
Genesis Biopharma Names Martin Schroeder to Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 9 Jun 2011
Northwest Biotherapeutics Announces Change and Expansion of Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Apr 2011
Cianna Medical Closes $12 Million in Funding for SAVI Breast Cancer Treatment
Devices Oncology Venture Capital

HSMN NewsFeed - 5 Jan 2011
Melanoma, Ovarian, and Prostate Cancer Treatment Guidelines for Patients Available from NCCN
Oncology

HSMN NewsFeed - 9 Dec 2010
New Multiple Myeloma Treatment Guidelines for Patients Available from NCCN
Biopharmaceuticals Oncology

HSMN NewsFeed - 20 Oct 2010
Genzyme Announces Results of Phase 3 Trial of Clolar in Adult AML
Biopharmaceuticals Oncology

HSMN NewsFeed - 12 Aug 2010
Mercator Licenses Pioneering Technology from MD Anderson Cancer Center and Closes $2M Seed Round
Biopharmaceuticals Oncology Venture Capital Licensing

HSMN NewsFeed - 3 Aug 2010
Toward the Future of Radiation Therapy: MD Anderson's Proton Therapy Center Pioneers Pencil Beam Technology for Cancer Patient Care
Devices Oncology

HSMN NewsFeed - 1 Jul 2010
Phase III Study Shows Novartis Drug Afinitor(R) More Than Doubles Time Without Tumor Growth in Advanced Pancreatic NET Patients
Biopharmaceuticals Oncology

HSMN NewsFeed - 26 May 2010
Researchers at MD Anderson Show That Positron Emission Mammography (PEM) Helps Evaluate Early Response to Neoadjuvant Chemotherapy
Devices Radiology Oncology

HSMN NewsFeed - 6 May 2010
Varian Medical Systems Equips Three Leading Cancer Centers in Istanbul with Advanced Radiotherapy Technology
Devices Oncology

HSMN NewsFeed - 26 Apr 2010
ThermoGenesis Extends Global Reach for Bone Marrow Products With New Distribution Agreements
Devices Regenerative Medicine Distribution

HSMN NewsFeed - 8 Apr 2010
Aeterna Zentaris Announces Initiation of Phase 3 Registration Trial with Perifosine in Refractory Advanced Colorectal Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 18 Feb 2010
BSD Medical Announces First Swiss Installation of the BSD-2000/3D Hyperthermia System at Kantonsspital Aarau
Devices Oncology

HSMN NewsFeed - 19 Jan 2010
ProGEL Lung Surgery Device Gets FDA Approval
Devices FDA

HSMN NewsFeed - 7 Dec 2009
Hana Biosciences Announces Positive Data From Pivotal rALLy Clinical Trial of Marqibo(R) in Acute Lymphoblastic Leukemia at 51st American Society of Hematology Annual Meeting
Biopharmaceuticals Drug Delivery Oncology

HSMN NewsFeed - 13 Nov 2009
Advances in Radiation Therapy Enable Doctors to Improve the Quality of Treatments for Patients With Head and Neck Cancer
Devices Oncology

HSMN NewsFeed - 12 Nov 2009
Repros Appoints Dr. Jaye Thompson to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Nov 2009
Arrowhead Subsidiary Calando Pharmaceuticals Expands Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Jul 2009
Cerulean Pharma Inc. Closes $10 Million Series B-1 Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 26 May 2009
FDA Grants Full Approval for SPRYCEL (dasatinib) for the Treatment of Adults with Chronic Myeloid Leukemia Who Are Resistant or Intolerant to Prior Therapies Including Gleevec*
Biopharmaceuticals Oncology

HSMN NewsFeed - 21 May 2009
Clovis Oncology Raises $145 Million in Start-Up Financing
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 8 May 2009
Archimedes Pharma Announces Ground Breaking Phase III Data Showing NasalFent to be Superior to the Standard of Care for Breakthrough Cancer Pain
Biopharmaceuticals Drug Delivery Oncology

HSMN NewsFeed - 8 Apr 2009
Cerulean Pharma Inc. Announces Appointment of Oliver S. Fetzer as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Feb 2009
Dr. D. Gary Gilliland, Internationally-Recognized Physician and Researcher, Joins Merck Research Labs as Head of Oncology Research
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Oct 2008
Deep Breeze Announces Latest Study Results on Vibration Response Imaging (VRI(TM)) at the 18th European Respiratory Society Congress
Devices

HSMN NewsFeed - 12 Sep 2008
Power3 Medical Products, Inc. Appoints Helen Park as Interim Chief Executive Officer
Diagnostics Personnel

HSMN NewsFeed - 30 Jun 2008
Hana Biosciences Receives U.S. Orphan Drug Designation for Marqibo for the Treatment of Metastatic Uveal Melanoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 24 Jun 2008
First Breast Cancer Patient Receives Treatment in National Electronic Brachytherapy Registry Launched by Three Physician Societies
Devices Oncology

HSMN NewsFeed - 17 Jun 2008
NeoMend Receives FDA Panel's Recommendation for Approval of ProGEL(TM) Surgical Sealant
Devices Surgery FDA

HSMN NewsFeed - 21 May 2008
American Urological Association (AUA) Clinical Guidelines Recognizes Cryotherapy as Treatment Option for Prostate Cancer Patients
Devices Urology

HSMN NewsFeed - 21 May 2008
AVANT Immunotherapeutics Announces Hart-Scott Rodino Clearance to License Cancer Vaccine to Pfizer
Biopharmaceuticals Licensing

HSMN NewsFeed - 25 Mar 2008
Micromet Establishes New Scientific Advisory Board for Its BiTE Antibody Technology with Leading Experts in the Fields of Oncology, Immunotherapy and Drug Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Mar 2008
Vasogen Provides Update on ACCLAIM II Program
Biopharmaceuticals Cardiology

HSMN NewsFeed - 26 Feb 2008
Ambrx Appoints Douglas Axelrod Senior Vice President for Clinical Research and Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Feb 2008
Adherex Receives Orphan Drug Designation for ADH-1 in Melanoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 31 Jan 2008
IDEV Technologies Inc. Receives 510(k) Clearance for New SUPERA(TM) Biliary Stent Delivery Catheter
Devices Interventional FDA

HSMN NewsFeed - 24 Jan 2008
Elekta: Procure Selects IMPAC as Provider of Oncology Information Systems
Devices Oncology

HSMN NewsFeed - 3 Jan 2008
Tempo Pharmaceuticals Closes $8 Million in Series B Funding
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 26 Dec 2007
Hitachi Receives FDA Clearance for Spot Scanning of PROBEAT Proton Beam Therapy System
Devices Oncology FDA

HSMN NewsFeed - 20 Nov 2007
Switzerland Receives First Hyperthermia Cancer Treatment System From BSD Medical
Devices Oncology

HSMN NewsFeed - 8 Nov 2007
FDA Approves New SPRYCEL(R) (Dasatinib) Product Labeling for Patients with Chronic-Phase CML
Biopharmaceuticals FDA Oncology

HSMN NewsFeed - 22 Oct 2007
Deep Breeze Ltd. Launches Unique Non-Invasive, Radiation-Free Pulmonary Imaging System in the U.S.
Devices

HSMN NewsFeed - 25 Sep 2007
ProCure Treatment Centers Teams with Forte Automation Systems to Enhance Proton Therapy for Cancer Patients
Devices Oncology

HSMN NewsFeed - 20 Sep 2007
Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
Biopharmacetuicals Oncology

HSMN NewsFeed - 17 Sep 2007
Vasogen Plans Confirmatory Study of Celacade(TM) in Chronic Heart Failure to Support U.S. Regulatory Approval
Biopharmaceuticals Cardiology

HSMN NewsFeed - 2 Aug 2007
OncoLogics, Inc., Signs Deal to Bring Proton Beam Radiation Therapy to Louisana
Devices Oncology

HSMN NewsFeed - 11 Jun 2007
Sunesis Pharmaceuticals Reports Positive Data From Studies of Two Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of the European Hematology Association
Biopharmaceuticals Oncology

HSMN NewsFeed - 5 Jun 2007
Biovest to File for Accelerated Conditional Approval of BiovaxID
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 2 Jun 2007
Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors
Biopharmaceuticals Oncology

HSMN NewsFeed - 2 Jun 2007
New Data Evaluating SUTENT, CP-751,871 and Axitinib in Patients with Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 23 May 2007
Tempo Pharmaceuticals Closes $12.1 Million in Series A Funding
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 22 May 2007
First Randomized Head-to-Head Study Shows Cryoablation at Least as Effective as External Beam Radiation for Treating Localized Prostate Cancer
Devices Oncology Urology

HSMN NewsFeed - 4 May 2007
Bristol-Myers Squibb Joins Oslo Cancer Cluster
Biopharmaceuticals Oncology

HSMN NewsFeed - 26 Apr 2007
Imalux Announces Major European Clinical Trials
Devices Radiology Oncology

HSMN NewsFeed - 16 Apr 2007
Data Presented at AACR Meeting Shows Peregrine's Selective Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical Cancer Models
Biopharmaceuticals Oncology

HSMN NewsFeed - 9 Apr 2007
ProCure Begins Construction on Oklahoma's First Proton Therapy Cancer Treatment Center
Devices Oncology

HSMN NewsFeed - 8 Mar 2007
Myriad Genetics Initiates Phase 2 Clinical Trial of Azixa(TM) in Brain Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 9 Nov 2006
Osiris Therapeutics Reports Positive Phase II Results Using PROCHYMAL(TM) for the Treatment of Acute Graft vs. Host Disease
Biopharmaceuticals Regenerative Medicine

HSMN NewsFeed - 4 Nov 2006
AMG 706 Shows Activity in Phase 2 Study of Patients with Advanced Imatinib-Resistant Gastrointestinal Stromal Tumors
Biopharmaceuticals Oncology

HSMN NewsFeed - 18 Sep 2006
Combination of High Dose QUADRAMET(R) and Chemotherapy Shows Promise for Treatment of High-Risk Acute Myeloid Leukemia
Biopharmaceuticals Oncology

Return to NewsFeed

Additional items found! 57

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 57 additional stories matching:
MD Anderson
(Password required)

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!